Leukemia
XV Eurasian Hematology-Oncology Congress - EHOC 2024
A Case of CMML With Recurrent Skin Involvement
FEATURING
Eren Arslan Davulcu
- September 16, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Critical Re-Evaluation of Established Practices in CML Management
FEATURING
Hagop Kantarjian
- 5 views
- September 16, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of R/R AML: Treatment Options and Case Insights
FEATURING
Valentina Bonuomo
- 18 views
- September 11, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in AML: 7+3 Is No Longer the Standard of Care
FEATURING
Tapan Kadia
- 81 views
- September 11, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Practical Approach to MRD Monitoring in AML: Assessing Treatment Efficacy and Relapse Risk
FEATURING
Tapan Kadia
- 6 views
- September 11, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in Ph+ ALL: Allo-SCT Should Be Used Upfront in Adult Patients
FEATURING
Dieter Hoelzer
- 18 views
- September 6, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in Ph+ ALL: Allo-SCT Is Not Necessary Upfront in Adult Patients
FEATURING
Elias Jabbour
- 16 views
- September 6, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
CLL Case Discussion: First Line Treatment Strategies
FEATURING
Damla Ortaboz
- 30 views
- September 6, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Incorporation of Targeted and Immunotherapies in ALL
FEATURING
Hagop Kantarjian
- 97 views
- August 30, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
The Importance of MRD in ALL
FEATURING
Farhad Ravandi
- 76 views
- August 29, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of AML in Older Patients
FEATURING
Farhad Ravandi
- 78 views
- August 29, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current Approaches to Managing T-Cell ALL
FEATURING
Ahmad Ibrahim
- 8 views
- August 28, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
TKI Toxicity Management in CML: A Case-Based Discussion
FEATURING
Awni Alshurafa
- 9 views
- August 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of Persistently MRD+ ALL
FEATURING
Asli Odabasi Giden
- 10 views
- August 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Debates in AML: 3+7 is the SOC Induction Therapy for AML
FEATURING
Ant Uzay
- 24 views
- August 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current Options for Finite-Duration Therapy With BTKis in CLL
FEATURING
Ahmad Ibrahim
- 63 views
- August 13, 2024